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The most promising approach in Tissue Engineering involves the seeding of porous, biocompatible/biodegradable scaﬀolds, with
donor cells to promote tissue regeneration. Additive biomanufacturing processes are increasingly recognized as ideal techniques
to produce 3D structures with optimal pore size and spatial distribution, providing an adequate mechanical support for tissue
regeneration while shaping in-growing tissues. This paper presents a novel extrusion-based system to produce 3D scaﬀolds with
controlled internal/external geometry for TE applications.The BioExtruder is a low-cost system that uses a proper fabrication code
basedontheISOprogramminglanguageenablingthefabricationofmultimaterialscaﬀolds.Poly(ε-caprolactone)wasthematerial
chosen to produce porous scaﬀolds, made by layers of directionally aligned microﬁlaments. Chemical, morphological, and in vitro
biological evaluation performed on the polymeric constructs revealed a high potential of the BioExtruder to produce 3D scaﬀolds
with regular and reproducible macropore architecture, without inducing relevant chemical and biocompatibility alterations of the
material.
Copyright © 2009 Marco Domingos et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Scaﬀolds are support structures used in tissue engineering
to provide the three-dimensional growth of cells in an
organized way. They are often critical, both in vitro and
in vivo, as they serve some of the following purposes [1–
4]: allow cell attachment, proliferation, and diﬀerentiation,
deliver and retain cells and growth factors, enable diﬀusion
of cell nutrients and oxygen, and enable an appropriate
mechanical and biological environment for organized tissue
regeneration.
The ideal scaﬀold should be biocompatible (not eliciting
adverse host tissue response), biodegradable into nontoxic
products with a controlled degradation rate, and possess
an optimized micro/macrostructural feature capable of
guarantying simultaneously both adequate vascularisation
and suﬃcient mechanical strength to withstand stresses in
the host tissue environment. An adequate surface topology
must also be achieved to promote cell-cell and cell-matrix
interactions.
The design, production, and characterization of tissue
engineering constructs are therefore demanding tasks in
regenerative medicine, namely, for load bearing tissues
such as bone and cartilage. Large pores and highly porous
structures are required to promote in vivo direct osteoge-
nesis (allowing vascularisation and proper oxygen supply
to the cells), while smaller pores result in osteochon-
dral ossiﬁcation. The interconnectivity of such pores is
also signiﬁcant because of cell migration, and therefore
vascularisation will be inhibited if pores are not intercon-
nected,evenifthestructurespresentanelevatedporosity[5].
Although highly porous structures enhance bone tissue
ingrowth, it also leads to a reduction in terms of mechanical
properties that may compromise the structural stability of
the scaﬀold. An upper limit for pore size and porosity may
than be established, based both on mechanical constraints
and host tissue pore dimensions [6]. The strength of a scaf-
fold is primarily dependent of the material bulk properties,2 International Journal of Biomaterials
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Figure 1: (a) Multimaterial extrusion system. (b) Single-material extrusion system.
(a) (b) (c)
Figure 2: Deposition strategies: (a) contour, (b) raster, (c) raster and contour.
but the fabrication method also plays an important role
conferring the opportunity to manipulate overall porosity.
The importance of pore size and spatial distribution for
eﬀective cell growth and tissue regeneration was underlined
by Oh et al. [7]. He reported an ideal pore size range of
380–405μm for chondrocytes and osteoblasts, 186–200μm
for ﬁbroblasts, and 290–310μm for bone formation.
Several techniques were developed to produce 3D
matrices suitable for tissue engineering, including non-
conventional techniques. These methods include Solvent
casting/salt leaching, Phase separation, Gas Foaming freeze
drying, among others. Despite being possible to control the
pore size and shape by changing the process parameters, the
interconnectivityandspatialdistributionoftheporesarestill
verypoor.Theselimitationsresultinpartiallyinterconnected
and randomly dispersed pores leading to an insuﬃcient
vascularisation and tissue ingrowth.
Additive fabrication processes represent a new group of
nonconventional techniques recently introduced in the med-
ical ﬁeld [8]. The main advantages of these techniques are
the capacity to rapidly produce very complex 3D models, the
ability to use various raw materials, and high reproducibility.
In the tissue engineering ﬁeld, additive technologies have
been used to produce scaﬀolds with customized external
shape and predeﬁned internal morphology, allowing a good
control of pore size and pore distribution [1].
Extrusion-based strategies to produce complex and
highly interconnected pore structures and the viability of
such structures to accommodate cells enabling its prolifera-
tion have been explored by several researchers [9–13]. How-
ever, during the fabrication process, materials undergo phase
change phenomena (solid-liquid-solid) under relatively high
temperature and pressure, on top of being subject to
relativelyhighshearratesduringtheextrusionprocess.These
phase change phenomena and the processing conditions
considered for each application may induce chemical and
physical transformations in a material. As a consequence, the
biocompatibility characteristics of the initial material can be
altered during its fabrication process.
This paper investigates the use of a novel BioExtruder
system to produce polymeric scaﬀolds for tissue engineering
applications, by examining the eﬀect of the processing
conditions in terms of the chemical-physical properties and
biocompatibility of the processed polymeric material.
The BioExtruder is an additive biomanufacturing sys-
tem under development for tissue engineering applicationsInternational Journal of Biomaterials 3
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Figure 3: Square and disc shape scaﬀolds produced by the BioExtruder.
14kV 1mm 44 32 SE I ×25
Figure 4: Scanning Electron Microscopy (SEM) micrograph of a
scaﬀold (top view).
13kV 33 32 SE I ×180 100 µM
Figure 5: SEM micrograph of ﬁlament adhesion detail.
[14, 15]. It is a highly reproducible and low-cost system
enabling the controlled deﬁnition of pores into the scaﬀold
to modulate mechanical strength and molecular diﬀusion, as
well the fabrication of multimaterial scaﬀolds. It comprises
two diﬀerent deposition systems: one rotational system for
multimaterial deposition acted by a pneumatic mechanism
and another one for a single material deposition that uses a
screw to assist the deposition process (Figure 1).
The rotational system has four reservoirs, two with
temperature control and two without. A large number of
nozzle diameters ranging from 0.1 to 1mm can be used.
The information ﬂowchart to produce scaﬀolds for tissue
engineering through this BioExtruder system comprises
three main steps. The ﬁrst one is the generation of the corre-
sponding computer solid model either directly by Computer
Aided Design (CAD) software or by using the data derived
from the currently available imaging techniques (magnetic
resonance or computer tomography). The computer solid
model is then tessellated as a stereolithography (STL) ﬁle,
which is currently the standard ﬁle for faceted models. For
multimaterial scaﬀolds, the BioExtruder system uses the
PLY (Polygon File Format) ﬁle format describing the model
through a list of ﬂat polygons. In this format, it is possible
to attribute diﬀerent properties and characteristics to each
polygon. Finally, the STL or PLY model is mathematically
sliced into thin layers (sliced model). Each layer is then
physically reproduced by the BioExtruder system.
Three scanning strategies were implemented for the
deposition process (Figure 2): contour, raster, and contour
and raster.
The deposition code, developed in Matlab (The Math-
Works, Inc.), is based on the ISO programming language,
commonly used to control Computer Numerical Control
(CNC) machines.
In addition, it should be stressed the fact that tissues
are organized in diﬀerent layers in the human body, with
diﬀerent physical and biological functions, and hence it
becomes important to produce scaﬀolds that can mimic this
functional hierarchy. The Bioextruder opens new perspec-
tives regarding the fabrication of these so called functionally
graded scaﬀolds by enabling the deposition of diﬀerent
materials at speciﬁc layers or by manipulating porosity and
pore size/shape through a set of process parameters.
2.MaterialsandMethods
2.1.Materials. Poly (ε-caprolactone)withMw50.000(CAPA
6500) in the form of 3mm pellets was obtained from
Perstorp Caprolactones (Cheshire, United Kingdom). Chlo-
roform used for GPC analysis was purchased from Sigma
Aldrich.4 International Journal of Biomaterials
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Figure 6: 3D images of the scaﬀolds surface topography obtained with AFM. (a) area 1; (b) area 2; (c) area 3.
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Figure 7: WST-1 cell proliferation assay performed on PCL extracts in solution with 3T3/A31 ﬁbroblasts: (a) processed PCL extracts; (b)
nonprocessed PCL extracts.
2.2. Scaﬀolds Design and Fabrication. AB i o E x t r u d e rd e v i c e ,
developed at the Polytechnic Institute of Leiria (I.P.L., Pt),
was used to fabricate the 3D porous scaﬀolds. Brieﬂy,
rectangular prisms, measuring 40 (length) × 40 (width)
× 8mm (height) with an average porosity of ∼76%, were
initially designed in a CAD software (SolidWorks, Dassault
Syst` emes S.A.). The STL ﬁle format was then transferred
to the BioExtruder slice generator software where it was
automatically sliced. This routine consists of a slicing
algorithm that slices the STL model into a number of 2D
layers of predeﬁned thickness to generate the contours of the
model (SLI ﬁle). The deposition strategy (raster deposition
strategy), scanning velocity, and ﬁlament distance for each
layer were directly programmed through the BioExtruder
scanning deposition generator routine, which was developed
basedontheISOprogramminglanguageforCNCmachines.
A 0/90 lay-down pattern was implemented in order to
produce a honeycomb-like pattern of fully interconnected
square pores. The information was then sent to the extrusion
equipment where the 3D structures were plotted in a layer-
by-layer fashion by applying an extrusion pressure and screw
rotation velocity of 6bar and 30rpm, respectively, enabling
the extrusion of the material through a 300μm nozzle. The
liqueﬁer and extrusion chamber temperature were set at
70
◦C, and ambient temperature remained at 25 ± 2◦C. The
3D structures were then removed from the building platform
and used for chemical and biological characterization as
described in the following sections.
2.3. Chemical Analysis
2.3.1. Gel Permeation Chromatography. The molecular
weight and the polydispersity of PCL samples were obtained
by gel permeation chromatography (GPC) using chloroform
as the eluent at a ﬂow rate of 1.0mL/min. The injection
volume was usually 50μL of stock solutions (0.5% w/v). A
Jasco PU-1580 HPLC liquid chromatograph connected toInternational Journal of Biomaterials 5
Jasco 830-RI and Perkin-Elmer LC-75 spectrophotometric
(λ = 260nm) detector, equipped with two PLgel 5μ mixed-D
columns, was used. The calibration curve was established by
using nine monodispersed polystyrene standards (Perkin-
Elmer) with molecular weight of 300, 233, 83, 50, 19, 4, 2.1,
0.8, and 0.5KDa, respectively.
2.3.2. Diﬀerential Scanning Calorimetry. The thermal prop-
erties were determined by diﬀerential scanning calorimetry
(DSC) using a Mettler TA 400 system instrument consisting
of DSC-30 diﬀerential scanning calorimeter. DSC samples of
6mgwereweighedin40μL aluminium pans; an empty pan
was used as reference. Measurements were carried out under
nitrogen atmosphere (nitrogen ﬂow rate of 80 mL/min). The
sample was submitted to a 1st heating from 30 to 90
◦C,
at a heating rate of 10
◦C/min, and then cooled from 90
to −100
◦C at a cooling rate of 10
◦C/min, followed by 4
minutes of isotherm. The 2nd heating scan was run from
−100 to 90
◦C at a heating rate of 10◦C/min. The melting
temperatures (Tm) were obtained at the peak of the melting
endotherms, while the glass transition temperatures (Tg)
weretakenattheinﬂectionpointofthespeciﬁcheatcapacity.
The enthalpies of fusion ( H f) were directly obtained from
the areas under the peaks. All values were taken from the
thermograms relevant to the second heating cycle. Indium
and gallium samples were used as calibration standards.
2.4. Scaﬀold Morphology
2.4.1. Scanning Electron Microscopy. Morphological analysis
of the 3D structures was carried out using a scanning
electron microscope (SEM, Jeol LSM 5600LV, Tokyo, Japan)
to visualize and evaluate the physical integrity of the material
ﬁlaments and layers, as well to understand if the previously
deﬁned pore geometry and size were maintained constant
during production.
2.4.2. Atomic Force Microscopy. A commercial AFM instru-
ment (Multimode microscope working with a Nanoscope IV
controller, Veeco Instr. Santa Barbara Ca. USA) was used to
evaluate the surface topography of the extruded ﬁlaments.
The AFM is equipped with a PicoForce stage allowing for
closed-loop scans in the Z direction (J-type scanner) and
thus endowing a precise and reliable movement along the
z axis, useful during elasticity measurements. The cantilever
used for imaging, an RTESP probe made of silicon, is 125μm
long and presents a typical oscillation frequency of 32KHz.
2.5. Biological Tests
2.5.1. Materials. Cell line BALB/3T3 Clone A31 mouse
embryo ﬁbroblasts (CCL163) was obtained from American
Type Culture Collection (ATCC) and propagated as indi-
cated by the supplier. Dulbecco’s Modiﬁed Eagles Medium
(DMEM), 0.01M pH 7.4 phosphate buﬀer saline without
Ca2+ and Mg2+ (PBS1), Calf Serum (CS), trypsine/EDTA,
glutamine, and antibiotics (penicillin/streptomycin) were
purchased from GIBCO Brl. Cell proliferation reagent WST-
1 was purchased from Roche Diagnostic. PhalloidinAlexa488
and 4 ,6-diamidino-2-phenylindole (DAPI) were purchased
from Invitrogen (NewYork, NY, USA). Tissue culture grade
disposable plastics were obtained from Corning Costar.
2.5.2. Cytotoxicity Tests on Extracts. To assess the cytotoxicity
of possible substances that could leach from both raw
and processed PCL, 0.2g of each material was placed
in 1mL of DMEM supplemented with 10% Calf Serum,
4mM L-Glutammine, and 100U/mL : 100μg/mL penicillin
: streptomycin for 48 hours at 37
◦Ci na ne n r i c h e d5 %C O 2
atmosphere. The medium containing the extracts was tested
undiluteed and diluted at a volume ratio of 1 : 1 and 1 : 4
using the complete culture medium. Balb/c 3T3 Clone A31
cells were seeded at a density of 1×103/well in a 96-well plate
and allowed to proliferate for 24 hours. Then the culture
media was changed with the DMEM containing the extracts,
and cells were allowed to proliferate for further 24 hours
at 37
◦Ci na5 %C O 2 enriched atmosphere. Cells incubated
with complete DMEM and wells containing only complete
DMEM were used as controls. At the end of the exposure
time, cell viability was measured using WST-1 tetrazolium
salt. Absorbance was measured at 450nm, and values relative
to control were reported. Experiments were performed in
triplicates.
2.5.3. Cell Adhesion and Proliferation onto PCL Scaﬀolds.
To investigate the ability of the prepared PCL scaﬀolds
to support cell adhesion and proliferation, samples were
sterilized with 70% ethanol/water solution for 24 hours,
washed extensively with PBS 0.01M pH 7.4 and exposed to
U.V light for 40 minutes.
Then cells were seeded at an appropriate density (3 ×
104cells/mL) directly onto the PCL scaﬀolds and allowed to
proliferate for 6 days. At the end of the incubation time
samples were analyzed for cell proliferation by means of
WST-1 tetrazolium salts as previously described.
For cell morphology investigations after six days of
culture samples were ﬁxed with 3.8% paraformaldehyde
solution in PBS 0.01M pH 7.4 for 1 hour and permeabilized
with Tritox X-100 for 15 minutes to enhance dyes binding
to cellular structure. A number of scaﬀolds were incubated
with toluidine blue for 1 hour under gently stirring and
extensively washed with PBS in order to stain cells for bright
ﬁeld observation.
Cell morphology was investigated also by confocal
laser scanning microscopy (CLSM) and scanning electron
microscopy (SEM). For CLSM after the permeabilization
step with Triton X-100, samples were incubated with a
PBS 0.01M solution of DAPI and phalloidin-Alexa633 for
45 minutes at room temperature. After dyeing incubation,
scaﬀolds were washed with PBS and cut into slices before
mounting on a glass slide and sealing with resin for
microscopic observation.
A Nikon Eclipse TE2000 inverted microscope equipped
with an EZ-C1 confocal laser (Nikon, Japan) and Diﬀerential6 International Journal of Biomaterials
50 µm
(a)
100 µm
(b)
Figure 8: Bright ﬁeld micrographs of mouse embryo ﬁbroblasts stained with toluidine blue after six days of culture onto PCL scaﬀolds.
(a) (b)
Figure 9: Confocal micrographs of mouse embryo ﬁbroblasts stained with DAPI (nuclei) and Phalloidin-Alexa633 (cytoskeleton) after 6
days of culture.
Interference Contrast (DIC) apparatus and a 60X oil-
immersion objective were used to analyze the samples. A
405nm laser diode (405nm emission) and Argon Ion Laser
(488 nm emission) were used to excite, respectively, DAPI
and FITC ﬂuorophores. Images were captured with Nikon
EZ-C1 software with identical settings for each sample.
Images were further processed with GIMP (GNU Free
Software Foundation) Image Manipulation Software and
merged with Nikon ACT-2U Software. For SEM analysis
samples were ﬁxed with solution of 2.5% glutaraldehyde in
PBS 0.01M for 1 hour at room temperature and dehydrated
by the use of a series of ethanol solutions (25%, 50%,
70% and 100% v/v). Afterward constructs were air dried
overnight at room temperature and sputter coated with
gold and analyzed by a JEOL LSM5600LV scanning electron
microscope. Statistical analysis is the following for every test,
the data are expressed as means plus or minus the standard
deviation(n = 3).Thestatisticalanalysiswasperformedwith
Students’ t-test at a 0.05 level.
3. Results andDiscussion
3.1. Scaﬀold Design and Fabrication. PCL scaﬀolds were
designed and produced with diﬀerent external geometries
(squared and circular shapes) and fully interconnected
square pores (Figure 3). One single lay-down pattern 0/90
◦
deposition strategy was adopted to generate the 3D struc-
tures. Process parameters, as shown in Table 1,w e r es e t
according to the material properties and scaﬀold geometry.
A morphological evaluation of the structures was carried
out under Scanning Electron Microscopy (SEM). The scaf-
folds produced with the BioExtruder present a well-deﬁned
internal geometry with square interconnected pores of reg-
ular dimensions (∼600×600μm) and uniform distribution,
when viewed from the Z direction of the fabrication process
(Figure 4). The extruded ﬁlaments show a regular circular
geometrywith ∼350μmdiameter,accordingtothenozzletip
used (300μm).
Adhesion between adjacent layers appeared to be good,
though mechanical tests need to be performed in the
future to quantitatively validate these results (Figure 5). The
microscopic analysis also conﬁrmed the acceptable level of
material homogeneity.
Scaﬀold porosity was determined according to the fol-
lowing equation:
Porosity = 1 −
ρ∗
ρsub
,( 1 )International Journal of Biomaterials 7
Table 1: Process conditions.
Process conditions
Reservoir temperature 70
◦C
Reservoir pressure 6bar
Screw velocity 30rpm
Extrusion chamber temperature 70
◦C
Extrusion nozzle diameter 0.30mm
Scanning velocity 8mm/s
Nozzle/platform distance 0.2mm
Table 2: AFM statistic results.
Statistics Scan area 1 Scan area 2 Scan area 3
Scan area (μm × μm) 100 25 225
Root mean squared of 213.5 140.2 360.1
pixel values (nm)
Standard deviation 65.8 43.0 48.8
where ρ∗ is the density of the cellular structure, and
ρsub is the density of the original substance. The produced
scaﬀolds porosity was found to be ∼76%.
The microporosity of a scaﬀold is an important param-
eter to determine both cell-scaﬀold and cell-cell interactions
during the adhesion and proliferation process on the surface
of the scaﬀolds. It is also important to produce ﬁlaments
neithertooﬂatnortoorough.Ifthesurfaceistoorough,cells
adhering to the ﬁlaments might not be able either to develop
distinct focal adhesion plaques or bridge the irregularities
and establish cell-cell interactions. Moreover, the sharpness
of the surface can physically damage the cell. Results of AFM
analysis performed on three diﬀerent areas of the scaﬀold
ﬁlaments are illustrated in Table 2 and Figure 6.
As previously mentioned, porosity and pore size/shape
plays an important role both on the mechanical and biolog-
ical performance of tissue engineering scaﬀolds. The struc-
tures produced with the BioExtruder present an elevated
porosity and large interconnected pores that are capable to
fulﬁl the requirements for appropriate vascularisation and
tissue growth. Depending upon the tissue to be regenerated,
the BioExtruder oﬀers the possibility to modulate the
biomechanical properties of the scaﬀolds, applying diﬀerent
process and design parameters.
3.2. Process Viability. Chemical and biological analyses were
performed to validate the bioextrusion process to produce
PCL scaﬀolds for tissue engineering applications.
Potentialdegradationorchemical/physicalmodiﬁcations
of the polymeric material, caused by the extrusion process,
was investigated by Gel Permeation Chromatography (GPC)
and Diﬀerential Scanning Calorimetry (DSC). The GPC
results, presented in Table 3, showed no particular modiﬁca-
tions in the molecular weight (Mn) and polydispersity index
(Mw/Mn), indicating a great stability of the polymer under
the selected fabrication conditions.
Through DSC analysis, it was possible to conﬁrm that
the crystalline fraction of PCL did not rise signiﬁcantly when
Table 3: Molecular weight distribution of processed and nonpro-
cessed PCL.
PCL Sample Sample Code Mn Mw Mw/Mn
Processed MD1 89900 123000 1.37
Nonprocessed MD 89500 127500 1.42
Table 4: Thermodynamics characteristics of PCL during second
heating scan.
PCL Sample Sample Code Tg (◦C) Tm (◦C) ΔHm (J/g)
Processed MD1 −60. 8 56.1 69.7
Nonprocessed MD −63. 5 57.0 72.0
the polymer was processed via bioextrusion. The values for
nonprocessed and processed PCL ranged between 50% and
52%, respectively. The thermodynamics characteristics of
both PCL samples are indicated in Table 4.
3.3. Biological Evaluation.
3.3.1. Cytotoxicity. Materials intended to be used for tissue
engineering applications should not release any agent that
may be cytotoxic. To know whether the prepared PCL
scaﬀolds extracts might be harmful to cells, the ﬁbroblast
cell line balb/c 3T3 Clone A31 was cultured in the presence
of the extractables of the unprocessed and bioextruded PCL
over 24 hours at 37
◦C, and WST-1 assay was carried out to
evaluate their potential cytotoxicity. Aqueous extracts of the
investigated samples, undiluted, diluted 1 : 1 and 1 : 4, were
used.Theresultofthisstudy,showninFigure 7,revealedthat
nosigniﬁcantreleaseofcytotoxiccompoundoccursfromthe
PCL material either before and after the bioextrusion process
and that cells not only remained viable but also proliferated
similartothecontrolalsointhecaseoftheundilutedextract.
3.3.2. Cell Adhesion and Proliferation onto PCL Scaﬀolds.
A preliminary biological evaluation of the prepared PCL
scaﬀolds to sustain cell adhesion and proliferation was
carried out by using the ﬁbroblast cell line balb/c 3T3 Clone
A31. Quantitative evaluation of cell proliferation onto the
bioextruded PCL scaﬀo l dw a sp e r f o r m e da f t e r6d a y so f
static culture by means of WST-1 tetrazolium salt. Results
highlighted a cell proliferation on the investigated sample
in the range of 15% in respect to the cells grown on tissue
culture polystyrene (TCPS), used as control. This fairly
low proliferation is probably due to the large pore size of
the prepared scaﬀolds that enables a large number of cells
not to settle on the ﬁlaments. Nevertheless, the parallel
investigations of cell morphology carried out by optical
microscopy revealed a signiﬁcant proliferation of the cells on
thesurfaceoftheﬁlamentswithaclearspreadingalongthem
and good morphology (Figure 8).
CLSM investigations conﬁrmed this observation, high-
lighting a general alignment of the actin ﬁbers of cells
cytoskeleton along the scaﬀold ﬁlaments and a nucleus with
normal morphology (Figure 9).8 International Journal of Biomaterials
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Figure 10: SEM micrographs of cells adhesion and spreading on the external and internal surface of the PCL scaﬀolds.
Inaddition,SEManalysisconﬁrmedtheadhesionofcells
both on the external and internal surface of the scaﬀolds
(Figure 10). These preliminary results appear very promis-
ing, and further experiments will be aimed at determining
the cell proliferation and morphology onto the bioextruded
scaﬀo l d sa f t e rl o n g e rp e r i o do fc u l t u r e .
4. Conclusions
The BioExtruder system was investigated and successfully
used to produce 3D porous scaﬀolds with fully intercon-
nected pores of regular geometry and dimension.
Results from chemical analysis demonstrated that no
signiﬁcant alterations were introduced in the material nei-
ther by the high temperatures or shear forces involved in
the melt/extrusion process. Cytotoxicity screening tests show
a high percentage of cell proliferation (>80%) whenever
3T3/A31 ﬁbroblasts were placed in contact with processed
material extracts, which seem to indicate that no substantial
quantities of toxic compounds were released from the
bioextruded PCL scaﬀold.
After 6 days of static cell culture, cells were able to
adhere and proliferate on the prepared scaﬀolds, showing
an alignment along the ﬁlaments. A qualitative cell adhesion
along with AFM evaluation allowed us to validate the
surface topography of the constructs, demonstrating that it
is possible to obtain structures with adequate topography
capable of promoting cell-surface and cell-cell interactions
through bioextrusion.
New deposition strategies are currently being explored in
order to obtain new geometries and consequently evaluate
their inﬂuence on both the mechanical and biological
properties of the structures.
In conclusion, these preliminary results not only conﬁrm
the high potential of the BioExtruder system to produce
PCL scaﬀolds for bone tissue engineering but also open
the possibility to explore the design and fabrication of
multimaterial scaﬀolds that can meet the functional and
biological requirements of the living tissues, through the
use of the rotational deposition system. This system, as
mentioned before, thanks to the four material chambers, two
with temperature control and two without activated by a
pneumatic mechanism, will enable further experiments for
the extrusion of 3D bioactive scaﬀolds that can incorporate
growth factors or living cells.
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